Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 68-76 , January 2010

Jack Bowman: Winnipeg's Contributions to the Treatment and Prevention of Rhesus Hemolytic Disease of the Newborn

References 

  1. Bowman JM. Acquired hemolytic anemia: Use of exchange transfusion in a crisis. Am J Dis Child. 1955;89:226–232
  2. Rapmund G, Bowman JM, Harris RC. Bilirubinemia in non-erythroblastic premature infants. 1. The correlation of peak plasma total bilirubin concentration with clinical course and post mortem findings in one hundred forty newborn premature infants. Am J Dis Child. 1960;99:604–616
  3. Millar RJ, Bowman JM. Oil of wintergreen (methyl salicylate) poisoning treated by exchange transfusion. Can Med Assoc J. 1961;84:956–957
  4. Uchida IA, Bowman JM, Wang HC. The 18 trisomy syndrome. New Eng J Med. 1962;266:198–201
  5. Bowman JM. Introduction of Dr Bruce Chown—Recipient of the Ross Award 1979. Can Paediatr Soc Newsl. 1979;XI:1–3
  6. Mollison P, Walker W. Controlled trials of the treatment of hemolytic disease of the newborn. Lancet. 1952;2:429–433
  7. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol. 1961;82:1359–1370
  8. Bowman JM, Pollock JM. Amniotic fluid spectrophotometry and early delivery in the management of erythroblastosis fetalis. Pediatrics. 1965;35:815–835
  9. Liley AW. Intrauterine transfusion of fetus in hemolytic disease. Br Med J. 1963;2:1107–1109
  10. Bowman JM, Friesen RF. Multiple intraperitoneal transfusions of the fetus for erythroblastosis fetalis. N Engl J Med. 1964;271:703–707
  11. Friesen RF, Bowman JM, Barnes PH, et al. Intrauterine foetal transfusions for erythroblastosis. A report on 100 consecutive operations. Am J Obstet Gynecol. 1967;97:343–349
  12. Bowman JM, Friesen RF, Bowman WD, et al. Fetal transfusion in severe Rh-isoimmunization. (indications, efficiency and results based on 218 transfusions carried out on 100 fetuses). JAMA. 1969;207:1101–1106
  13. Sadler J. Fighting for the unborn. Dr. Jack Bowman's war on a killer. Winnipeg Tribune Magazine. 1980;7:8–13
  14. Bowman J. Historical overview of Rh immunization and hemolytic disease of the newborn. Manit Med. 1992;62:134–136
  15. Barnes PH, McInnis C, Friesen RF, et al. Maternal mishap following fetal transfusion. Can Med Assoc J. 1977;92:1277–1278
  16. Pollock J, Bowman JM, Manning FA, et al. Fetal blood sampling in Rh hemolytic disease. Vox Sang. 1987;53:139–142
  17. Bowman JM. The management of hemolytic disease in the fetus and newborn. Semin Perinatol. 1997;21:39–44
  18. Chown B. Anemia in a newborn due to the fetus bleeding into the mother's circulation, proof of bleeding. Lancet. 1954;i:1213–1214
  19. Zipursky A, Israels LG. Foetal erythrocytes in the maternal circulation. Lancet. 1959;2:451–452
  20. Zimmerman DR. Rh. The Intimate History of a Disease and its Conquest. New York: MacMillan Publishing Co. Inc.; 1973;
  21. In:  Zallen DT,  Christie DA,  Tansey EM editor. The Rhesus factor and disease prevention. Wellcome Witnesses to the Twentieth Century Medicine. Vol. 22:London: The Wellcome Trust; 2004;
  22. Friesen RF, Bowman JM. The role played by Rh immunization in pregnancy wastage. Can Med Assoc J. 1965;93:1333–1335
  23. Clarke CA, Sheppard PM. Prevention of rhesus hemolytic disease. Lancet. 1965;2:343;(letter)
  24. Freda VJ, Gorman JG, Pollack W. Prevention of rhesus hemolytic disease. Lancet. 1965;2:690;(letter)
  25. Smith T. Active immunity produced by so called balanced or neutral mixtures of diphtheria toxin and antitoxin. J Exp Med. 1909;11:241–256
  26. Bowman JM, Peddle LJ, Anderson C. Plasmapheresis in severe Rh-isoimmunization. Vox Sang. 1968;15:272–277
  27. Zimmerman DR. Rh. The Intimate History of a Disease and its Conquest. In: Chapter 26. Secret meeting at the Waldorf. New York: MacMillan Publishing Co. Inc.; 1973;p. 269
  28. Chown B, et al. Prevention of primary Rh immunization: First report of the Western Canadian Trial 1966-1968. Can Med Assoc J. 1969;100:1021–1024
  29. Zipursky A, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J. 1967;97:1245–1257
  30. Bowman JM, Chown B. Prevention of Rh immunization after massive Rh-positive transfusion. Can Med Assoc J. 1968;99:385–388
  31. Bowman JM. Editorial. Prevention of Rh immunization. Can Med Assoc J. 1970;103:1810–1811
  32. Bowman JM. Annotation. Prevention of hemolytic disease of the newborn. Br J Haematol. 1970;19:653–655
  33. Shumacher GFB, Schneider J. Coordinators: Current problems in prophylactic treatment of Rh-erythroblastosis. An invitational symposium. J Report Med. 1971;6:67–90
  34. Bowman JM. Editorial. Hemolytic disease of the newborn. Can Med Assoc J. 1974;111:381–382
  35. Bowman JM, Chown B, Lewis M, et al. Rh isoimmunization, Manitoba, 1963-75. Can Med Assoc J. 1977;116:282–284
  36. Bowman JM, Chown B, Lewis M, et al. Rh isoimmunization during pregnancy: Antenatal prophylaxis. Can Med Assoc J. 1978;118:623–627
  37. Bowman JM, Pollock JM. Antenatal prophylaxis Rh isoimmunization: 28 weeks'-gestation service program. Can Med Assoc J. 1978;118:627–630
  38. Zipursky A. Editorial. The conquest of Rh disease. Can Med Assoc J. 1978;118:609–610
  39. Hoppe HH, Mester T, Hennig W, et al. Prevention of Rh-immunization. Modified production of IgG anti-Rh for intravenous application by ion exchange chromatography (IEC). Vox Sang. 1973;25:308–316
  40. Cunningham CJ. Production of human immunoglobulin anti-D (Rho) for intravenous administration, for a national Rh prophylaxis programme. Biochem Soc Trans. 1980;8:178–179
  41. Friesen AD, Bowman JM. Column ion exchange preparation and characterization of an Rh immune globulin for intravenous use: WinRho. J Appl Biochem. 1981;3:164–175
  42. Bowman JM, Friesen AD, Pollock JM, et al. WinRho: Rh Immune globulin prepared by ion exchange for intravenous use. Can Med Assoc J. 1980;123:1121–1127
  43. Kelton JG. Editorial. Eradication of Rh hemolytic disease of the newborn. Can Med Assoc J. 1980;123:1089–1091
  44. Bowman JM, Pollock J. Rh immunization in Manitoba: Progress in prevention and management. Can Med Assoc J. 1983;129:343–345
  45. Personal communication. Dr. Bonnie Cham: Director Rh Laboratory, 2008.
  46. Wegmann A, Glück R. The history of rhesus prophylaxis with anti-D. Eur J Pediatr. 1996;155:835–838
  47. Bowman JM. Commentary: Thirty-five years of Rh prophylaxis. Transfusion. 2003;43:1661–1666

PII: S0887-7963(09)00087-X

doi: 10.1016/j.tmrv.2009.09.007

Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 68-76 , January 2010

Article Tools

* Image Usage & Resolution